Sequencing Framework for the Sensitive Detection and Precise Mapping of Defective Interfering Particle-Associated Deletions across Influenza A and B Viruses.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
01 06 2019
Historique:
received: 01 03 2019
accepted: 06 03 2019
pubmed: 15 3 2019
medline: 24 6 2020
entrez: 15 3 2019
Statut: epublish

Résumé

The mechanisms and consequences of defective interfering particle (DIP) formation during influenza virus infection remain poorly understood. The development of next-generation sequencing (NGS) technologies has made it possible to identify large numbers of DIP-associated sequences, providing a powerful tool to better understand their biological relevance. However, NGS approaches pose numerous technical challenges, including the precise identification and mapping of deletion junctions in the presence of frequent mutation and base-calling errors, and the potential for numerous experimental and computational artifacts. Here, we detail an Illumina-based sequencing framework and bioinformatics pipeline capable of generating highly accurate and reproducible profiles of DIP-associated junction sequences. We use a combination of simulated and experimental control data sets to optimize pipeline performance and demonstrate the absence of significant artifacts. Finally, we use this optimized pipeline to reveal how the patterns of DIP-associated junction formation differ between different strains and subtypes of influenza A and B viruses and to demonstrate how these data can provide insight into mechanisms of DIP formation. Overall, this work provides a detailed roadmap for high-resolution profiling and analysis of DIP-associated sequences within influenza virus populations.

Identifiants

pubmed: 30867305
pii: JVI.00354-19
doi: 10.1128/JVI.00354-19
pmc: PMC6532088
pii:
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI139246
Pays : United States

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

J Clin Microbiol. 2014 May;52(5):1330-7
pubmed: 24501036
J Virol Methods. 2010 Oct;169(1):248-52
pubmed: 20691210
Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20166-71
pubmed: 22135472
Curr Top Microbiol Immunol. 1985;114:103-51
pubmed: 3888540
J Virol. 2009 Oct;83(19):10309-13
pubmed: 19605485
PLoS Pathog. 2017 May 5;13(5):e1006365
pubmed: 28475646
J Virol. 2013 Jul;87(14):8064-74
pubmed: 23678180
Nucleic Acids Res. 2014 Jan;42(2):e11
pubmed: 24137010
PLoS Pathog. 2017 Oct 12;13(10):e1006650
pubmed: 29023600
J Mol Biol. 2015 Aug 14;427(16):2610-6
pubmed: 26116762
Cell. 1983 Sep;34(2):619-27
pubmed: 6616623
PLoS Pathog. 2018 Jan 18;14(1):e1006796
pubmed: 29346435
Nat Protoc. 2014 Jul;9(7):1760-9
pubmed: 24967624
Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16303-8
pubmed: 20805493
PLoS One. 2008 Oct 08;3(10):e3373
pubmed: 18841204
J Gen Virol. 2010 Feb;91(Pt 2):313-28
pubmed: 19955561
Nat Methods. 2018 Mar;15(3):201-206
pubmed: 29334379
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Front Microbiol. 2016 Mar 23;7:326
pubmed: 27047455
J Virol. 2017 Oct 27;91(22):
pubmed: 28855247
Biotechniques. 2009 Oct;47(4):857-66
pubmed: 19852769
Curr Opin Virol. 2018 Dec;33:74-80
pubmed: 30099321
J Virol. 2019 May 15;93(11):
pubmed: 30867305
Virology. 1979 May;95(1):48-58
pubmed: 442544
Acta Pathol Microbiol Scand. 1951;28(3):278-93
pubmed: 14856732
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Nat Biotechnol. 2012 May;30(5):434-9
pubmed: 22522955
J Gen Virol. 2016 Feb;97(2):306-315
pubmed: 26675486
J Virol. 2014 Mar;88(5):2623-32
pubmed: 24352442
Nucleic Acids Res. 2015 Mar 31;43(6):e37
pubmed: 25586220
Adv Virus Res. 1954;2:59-79
pubmed: 13228257

Auteurs

Fadi G Alnaji (FG)

Department of Microbiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.

Jessica R Holmes (JR)

Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
High-Performance Biological Computing at the Roy J. Carver Biotechnology Center, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.

Gloria Rendon (G)

Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
High-Performance Biological Computing at the Roy J. Carver Biotechnology Center, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.

J Cristobal Vera (JC)

Department of Microbiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.

Christopher J Fields (CJ)

Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
High-Performance Biological Computing at the Roy J. Carver Biotechnology Center, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.

Brigitte E Martin (BE)

Department of Microbiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.

Christopher B Brooke (CB)

Department of Microbiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA cbrooke@illinois.edu.
Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH